BioXcel Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BTAI and other ETFs, options, and stocks.

About BTAI

BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in utilizing artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology. The firm offers IGALMI, a proprietary, sublingual film formulation of dexmedetomidine for the acute treatment of agitation associated with schizophrenia or bipolar disorder in adults. 

CEO
Vimal D. Mehta
CEOVimal D. Mehta
Employees
89
Employees89
Headquarters
New Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded
2017
Founded2017
Employees
89
Employees89

BTAI Key Statistics

Market cap
331.79M
Market cap331.79M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
220.37K
Average volume220.37K
High today
$12.05
High today$12.05
Low today
$11.25
Low today$11.25
Open price
$11.34
Open price$11.34
Volume
227.03K
Volume227.03K
52 Week high
$36.49
52 Week high$36.49
52 Week low
$8.80
52 Week low$8.80

Analyst ratings

89%

of 9 ratings
Buy
88.9%
Hold
0%
Sell
11.1%

BTAI Earnings

-$1.35
-$0.90
-$0.45
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 10, Pre-Market
ActualExpected Nov 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.